Technology Investment & Licensing

Home Technology Investment & Licensing Research Innovation Portfolio Biotechnology & Life Sciences Autoimmune & inflammatory diseases

Autoimmune & inflammatory diseases

Here’s a sample of UniQuest’s projects looking for commercial partners. If you would like more information on a project, let us know you’re interested using the Quick Query form.

  1. Helmedix - Helminth Defence Molecules
  2. Ankylosing Spondylitis - arthritis diagnostic
  3. Dendright Pty Ltd
  4. C3A Agonists
  5. Tolergentide - multiple sclerosis therapy
  6. MSPep - multiple sclerosis therapy
  7. Engineered Gal2 - immune-related disease modulator

Sign up to receive all the latest news about UniQuest’s investment and licensing portfolio with The Deal Sheet, or visit our News pages.

Back to Research Innovation Portfolio

Autoimmune, inflammatory diseases, multiple sclerosis, arthritis, diabetes, rheumatoid arthritis, allergy, IBD, irritable bowel